Clinical Trial: Sildinafil in Pulmonary Hypertension-Rheumatic Chronic Valvular Disease(RCT)
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition:
Pulmonary Hypertension
Rheumatic Valvular Heart Disease
Study Type: INTERVENTIONAL
Official Title: Efficacy of Sildenafil in Severe Pulmonary Hypertension Secondary to Rheumatic Chronic Valvular Disease: A Double-Blinded Placebo Randomized Control Trial
Brief Summary:
Pulmonary hypertension secondary to left heart disease is associated with increased morbidity and mortality, particularly in patients with rheumatic chronic valvular heart disease, which remains highly prevalent in low- and middle-income countries. These patients often present late with severe pulmonary hypertension, limiting surgical options and worsening outcomes. Sildenafil, a phosphodiesterase-5 inhibitor, has demonstrated benefit in various forms of pulmonary hypertension; however, its role in pulmonary…
Read more